UNH changes
Pick any two versions below to diff them.
- Price
- $400.32 → $376.59(−5.9%)
- Next earnings
- Oct 27, 2026 → Oct 13, 2026
- Thesis
- removed: In 2025, UnitedHealth's removed: medical costs rose faster than expected, added: 2025 cost spike, mainly in Medicare removed: Advantage. This added: Advantage, forced removed: the company to withdraw its 2025 added: a guidance added: withdrawal and removed: replace its CEO. The added: a CEO change. It left the market removed: worries about an ongoing added: pricing the stock as though the business is still troubled. The medical care ratio has since improved for several straight quarters. The case for a re-rating rests on that trend continuing rather than reversing. It also rests on the outcome of the Department of removed: Justice added: Justice's investigation into Medicare Advantage removed: billing, and about lasting reputational damage from the killing of added: billing. A large fine or a removed: UnitedHealthcare executive in December added: forced change to risk-coding practices would cut future revenue. A resolution with limited financial impact would remove a source of negative attention that has weighed on the stock since 2024. removed: Since then, new added: New management removed: has delivered several straight quarters of improving added: is also selling down stakes in underperforming clinics, such as a September 2026 deal with TPG for Florida clinics, and cutting prior-authorization requirements starting October 2026. Both steps are meant to show the business model still works without the practices under scrutiny. The next Q3 2026 results, due October 13, 2026, will show whether the medical removed: cost ratios added: care ratio keeps improving into the back half of the year. If it does, and removed: stronger Optum results. Continued improvement added: the DOJ matter resolves without a severe penalty, the discount can removed: show added: close over the removed: market that added: next two to four quarters. If a large fine or forced billing changes arrive instead, the removed: 2025 cost spike was temporary, not permanent. added: market's caution would prove correct, and the stock could stay discounted well into 2027.
- Recent events
- added: Sep 9, 2026: UnitedHealth sold a minority stake in a group of Florida WellMed clinics, which focus on older patients, to private-equity firm TPG. Optum keeps an ownership interest and stays in the local market. Jul 16, 2026: UnitedHealth reported Q2 2026 revenue of $112.0 billion. The medical care ratio improved to 86.7%, from 89.4% a year earlier, and management raised full-year guidance. May 13, 2025: UnitedHealth withdrew its full-year 2025 earnings guidance. CEO Andrew Witty stepped down, and Stephen Hemsley returned as CEO.